Adalimumab and azathioprine in the prevention of postoperative crohn’s disease recurrence
Introduction. Despite improvements in earlier diagnosis and the development of conservative therapy for Crohn’s disease (CD), approximately 70%–80% of patients undergo surgical treatment for complications. Surgical treatment is not a cure for this disease. The question of choosing therapy as a preve...
| Published in: | Медицинский совет |
|---|---|
| Main Authors: | A. V. Poletova, M. V. Shapina |
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2020-10-01
|
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/5836 |
Similar Items
Azathioprine-Induced Acute Submandibular Sialadenitis in a Crohn’s Disease Patient
by: Joana Inês Alves da Silva, et al.
Published: (2020-01-01)
by: Joana Inês Alves da Silva, et al.
Published: (2020-01-01)
Efficacy of Adalimumab in Korean Patients with Crohn’s Disease
Published: (2016-03-01)
Published: (2016-03-01)
Pulmonary Mycobacterium avium Infection in a Patient with Crohn's Disease under Azathioprine Treatment
by: Tomonori Hirano, et al.
Published: (2014-05-01)
by: Tomonori Hirano, et al.
Published: (2014-05-01)
How Does It Look in an Autopsy? Hepatosplenic T-Cell Lymphoma in a Patient with Crohn's Disease on Azathioprine
by: Pulkit Rastogi, et al.
Published: (2020-08-01)
by: Pulkit Rastogi, et al.
Published: (2020-08-01)
Gastrointestinal lymphoma in a patient on long-term azathioprine therapy: A case report with imaging features mimicking Crohn's disease
by: Trang Truong Hoang Nguyen, MD, et al.
Published: (2025-06-01)
by: Trang Truong Hoang Nguyen, MD, et al.
Published: (2025-06-01)
Crohn’s Disease Associated Pyoderma Gangrenosum Treated with Adalimumab
by: Despoina Kakagia, et al.
Published: (2012-03-01)
by: Despoina Kakagia, et al.
Published: (2012-03-01)
Leukocytoclastic Vasculitis Associated with Adalimumab Therapy for Crohn’s Disease
by: Lankai Cathy Xu, et al.
Published: (2023-03-01)
by: Lankai Cathy Xu, et al.
Published: (2023-03-01)
Comparison of Long-term Outcomes of Infliximab versus Adalimumab in 1,488 Biologic-Naive Korean Patients with Crohn’s Disease
by: Yoon Suk Jung, et al.
Published: (2021-01-01)
by: Yoon Suk Jung, et al.
Published: (2021-01-01)
Mesenchymal stromal cells of bone marrow and azathioprine in Crohn's disease therapy
by: O V Knyazev, et al.
Published: (2018-02-01)
by: O V Knyazev, et al.
Published: (2018-02-01)
Adalimumab induced psoriasis in a Crohn’s disease patient: a case report
by: Dhaifallah Alrakawi Alenizi
Published: (2024-06-01)
by: Dhaifallah Alrakawi Alenizi
Published: (2024-06-01)
Listeria Monocytogenes Brain Abscess in Crohn’s Disease Treated with Adalimumab
by: Amporn Atsawarungruangkit, et al.
Published: (2017-11-01)
by: Amporn Atsawarungruangkit, et al.
Published: (2017-11-01)
Safety and Efficacy of Adalimumab for Patients With Moderate to Severe Crohn's Disease: The Taiwan Society of Inflammatory Bowel Disease (TSIBD) Study
by: Chen-Wang Chang, et al.
Published: (2014-10-01)
by: Chen-Wang Chang, et al.
Published: (2014-10-01)
Adalimumab for endoscopic and histopathological mucosal healing in paediatric patients with moderate to severe Crohn’s disease
by: Edyta Szymanska, et al.
Published: (2016-12-01)
by: Edyta Szymanska, et al.
Published: (2016-12-01)
Distinct alterations of fecal microbiota refer to the efficacy of adalimumab in Crohn’s disease
by: Liang Chen, et al.
Published: (2022-08-01)
by: Liang Chen, et al.
Published: (2022-08-01)
Evaluation of low doses of Azathioprine in reducing relapse and corticosteroid dependence in patients with Ulcerative Colitis
by: Maryam Rezaiee, et al.
Published: (2019-05-01)
by: Maryam Rezaiee, et al.
Published: (2019-05-01)
A HISTORY CASE OF ADALIMUMAB TREATMENT IN A FEMALE PATIENT WITH JUVENILE ARTHRITIS AND UVEITIS AS MANIFESTATIONS OF CROHN’S DISEASE
by: V. A. Malievskii, et al.
Published: (2013-07-01)
by: V. A. Malievskii, et al.
Published: (2013-07-01)
Adalimumab induction and maintenance therapy achieve clinical remission and response in Chinese patients with Crohn's disease
by: Kai-Chun Wu, et al.
Published: (2016-04-01)
by: Kai-Chun Wu, et al.
Published: (2016-04-01)
Managing Crohn’s Disease Postoperative Recurrence Beyond Prophylaxis: A Comprehensive Review with Meta-Analysis
by: Andrei Ovidiu Olteanu, et al.
Published: (2024-10-01)
by: Andrei Ovidiu Olteanu, et al.
Published: (2024-10-01)
Adalimumab Monotherapy in the Treatment of Idiopathic Multifocal Choroiditis: A Case Report
by: Arash Maleki, et al.
Published: (2022-11-01)
by: Arash Maleki, et al.
Published: (2022-11-01)
Comparison Between Adalimumab and Infliximab in Perianal Crohn’s Disease: A Systematic Review and Meta-Analysis
by: Tarek Aboursheid, et al.
Published: (2025-01-01)
by: Tarek Aboursheid, et al.
Published: (2025-01-01)
A Randomized Double‐Blind, Placebo‐Controlled Trial of Artesunate and Curcumin in Patients With Crohn's Disease: A Pilot Study
by: Devinder Kumar, et al.
Published: (2025-07-01)
by: Devinder Kumar, et al.
Published: (2025-07-01)
Identification of Novel Loci Involved in Adalimumab Response in Crohn’s Disease Patients Using Integration of Genome Profiling and Isoform-Level Immune-Cell Deconvoluted Transcriptome Profiling of Colon Tissue
by: Mario Gorenjak, et al.
Published: (2022-09-01)
by: Mario Gorenjak, et al.
Published: (2022-09-01)
Two Cases of Paradoxical Hidradenitis Suppurativa while on Adalimumab
by: Glenn Harvin, et al.
Published: (2016-05-01)
by: Glenn Harvin, et al.
Published: (2016-05-01)
Summary of Research: Immunogenicity of Adalimumab Reference Product and Adalimumab-adbm in Patients with Rheumatoid Arthritis, Crohn’s Disease, and Chronic Plaque Psoriasis: A Pooled Analysis of the VOLTAIRE trials
by: Vibeke Strand
Published: (2025-06-01)
by: Vibeke Strand
Published: (2025-06-01)
Febrile neutropenia associated with adalimumab in a patient with ulcerative colitis
by: Ma’In Atallah Mohammad Abumuhfouz, et al.
Published: (2024-04-01)
by: Ma’In Atallah Mohammad Abumuhfouz, et al.
Published: (2024-04-01)
Azathioprine as an adjuvant therapy in severe Graves’ disease: a randomized controlled open-label clinical trial
by: Magdy Mohamed Allam, et al.
Published: (2023-06-01)
by: Magdy Mohamed Allam, et al.
Published: (2023-06-01)
Characteristics of patients who developed transient anti-adalimumab antibodies
by: Osama Elaraby, et al.
Published: (2025-09-01)
by: Osama Elaraby, et al.
Published: (2025-09-01)
Crohn's disease confined to the esophagus, with no involvement of the small or large bowel
by: Karam Karam, et al.
Published: (2024-10-01)
by: Karam Karam, et al.
Published: (2024-10-01)
Adalimumab Serum Concentrations, Clinical and Endoscopic Disease Activity in Crohn’s Disease: A Cross-Sectional Multicentric Latin American Study
by: Letícia Rodrigues de Souza, et al.
Published: (2023-02-01)
by: Letícia Rodrigues de Souza, et al.
Published: (2023-02-01)
Vitiligo during Treatment of Crohn’s Disease with Adalimumab: Adverse Effect or Co-Occurrence
by: Celia Posada, et al.
Published: (2011-02-01)
by: Celia Posada, et al.
Published: (2011-02-01)
Adalimumab induced psoriasis in Crohn’s disease and treatment with ustekinumab: case report and special histopathological findings
by: Fang Qiu, et al.
Published: (2025-01-01)
by: Fang Qiu, et al.
Published: (2025-01-01)
Self‐Injection Satisfaction and Safety of CT‐P17 (Yuflyma), a High‐Concentration Adalimumab Biosimilar, in Patients With Crohn's Disease: A Cross‐Sectional Study
by: Fei Yang Pan, et al.
Published: (2025-08-01)
by: Fei Yang Pan, et al.
Published: (2025-08-01)
Bilateral corneal pannus in Crohn's disease and assumed adalimumab-associated ocular surface disease
by: Nefeli Eleni Kounatidou, et al.
Published: (2025-12-01)
by: Nefeli Eleni Kounatidou, et al.
Published: (2025-12-01)
Adalimumab induced psoriasis during the treatment of inflammatory bowel disease – case report
by: Edyta Lelonek, et al.
Published: (2015-09-01)
by: Edyta Lelonek, et al.
Published: (2015-09-01)
Pyoderma Gangrenosum in a Patient with Crohn’s Disease Treated with Adalimumab: A Case-Based Review and Systematic Review of the Current Literature
by: Fotios S. Fousekis, et al.
Published: (2025-03-01)
by: Fotios S. Fousekis, et al.
Published: (2025-03-01)
IgA Nephropathy in a Patient Treated with Adalimumab
by: Tonja Mertelj, et al.
Published: (2021-07-01)
by: Tonja Mertelj, et al.
Published: (2021-07-01)
The Effect of Drugs on the Intestinal Microbiota in Crohn’s Disease
by: Xue Yang, et al.
Published: (2024-10-01)
by: Xue Yang, et al.
Published: (2024-10-01)
Combination Therapy with Intensive Granulocyte and Monocyte Adsorptive Apheresis plus Adalimumab: Therapeutic Outcomes in 5 Cases with Refractory Crohn’s Disease
by: Keiji Ozeki, et al.
Published: (2012-12-01)
by: Keiji Ozeki, et al.
Published: (2012-12-01)
Azathioprine Hypersensitivity Syndrome: Two Cases of Febrile Neutrophilic Dermatosis Induced by Azathioprine
by: Majed Aleissa, et al.
Published: (2017-01-01)
by: Majed Aleissa, et al.
Published: (2017-01-01)
Factors Contributing to the Preference of Korean Patients with Crohn’s Disease When Selecting an Anti-Tumor Necrosis Factor Agent (CHOICE Study)
Published: (2016-05-01)
Published: (2016-05-01)
Similar Items
-
Azathioprine-Induced Acute Submandibular Sialadenitis in a Crohn’s Disease Patient
by: Joana Inês Alves da Silva, et al.
Published: (2020-01-01) -
Efficacy of Adalimumab in Korean Patients with Crohn’s Disease
Published: (2016-03-01) -
Pulmonary Mycobacterium avium Infection in a Patient with Crohn's Disease under Azathioprine Treatment
by: Tomonori Hirano, et al.
Published: (2014-05-01) -
How Does It Look in an Autopsy? Hepatosplenic T-Cell Lymphoma in a Patient with Crohn's Disease on Azathioprine
by: Pulkit Rastogi, et al.
Published: (2020-08-01) -
Gastrointestinal lymphoma in a patient on long-term azathioprine therapy: A case report with imaging features mimicking Crohn's disease
by: Trang Truong Hoang Nguyen, MD, et al.
Published: (2025-06-01)
